Follow-up during treatment
leishmaniasis
ADVERSE EVENTS, LEISHMANIASIS
In the case of patients who received any part of their treatment at the CIDEIM health facility in the town of Tumaco, monitoring was carried out by CHV, liaising with the health facility. For those patients who resided in villages where there was no CHV to supervise the treatment, monitoring was coordinated with CHV from other communities. In addition to the app, a standard paper form was also used by CHV to monitor treatment adherence and adverse events for all study participants, as is done for all leishmaniasis patients in CIDEIM. In addition, for those in the app arm, weekly monitoring of treatment was performed via the mobile application (Guaral+ST), recording the number of doses received and the adverse events, including their severity and frequency. At each visit, i.e. prior to treatment, at the end of the treatment, and at weeks 7,13, and 26, a photograph of each lesion was taken with the mobile phone by CHVs. Study procedures are summarized in 